Decision time for pancreatic islet-cell transplantation

The Lancet

Volumn 371, Issue 9616, 2008, Pages 883-884

  Ruggenenti, Piero ^a,b   Remuzzi, Andrea ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; DOXYCYCLINE; RAPAMYCIN; TACROLIMUS; TETRACYCLINE DERIVATIVE; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CELL THERAPY; CELL TRANSPLANTATION; CLINICAL TRIAL; DONOR; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; IMMUNE DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MEDICAL DECISION MAKING; METABOLIC REGULATION; NEPHROTOXICITY; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; PROMOTER REGION; XENOGRAFT;

EID: 40649100975     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60395-5     Document Type: Note

References (12)